Literature DB >> 30872118

Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1β secretion by bronchoalveolar fluid macrophages from asthmatic subjects.

Elizabeth M Gordon1, Xianglan Yao1, Haitao Xu1, William Karkowsky1, Maryann Kaler1, Or Kalchiem-Dekel1, Amisha V Barochia1, Meixia Gao1, Karen J Keeran2, Kenneth R Jeffries2, Stewart J Levine3.   

Abstract

BACKGROUND: House dust mite (HDM)-challenged Apoe-/- mice display enhanced airway hyperreactivity and mucous cell metaplasia.
OBJECTIVE: We sought to characterize the pathways that induce apolipoprotein E (APOE) expression by bronchoalveolar lavage fluid (BALF) macrophages from asthmatic subjects and identify how APOE regulates IL-1β secretion.
METHODS: Macrophages were isolated from asthmatic BALF and derived from THP-1 cells and human monocytes.
RESULTS: HDM-derived cysteine and serine proteases induced APOE secretion from BALF macrophages through protease-activated receptor 2. APOE at concentrations of less than 2.5 nmol/L, which are similar to levels found in epithelial lining fluid from healthy adults, did not induce IL-1β release from BALF macrophages. In contrast, APOE at concentrations of 25 nmol/L or greater induced nucleotide-binding oligomerization domain, leucine-rich repeat-containing protein (NLRP) 3 and pro-IL-1β expression by BALF macrophages, as well as the caspase-1-mediated generation of mature IL-1β secreted from cells. HDM acted synergistically with APOE to both prime and activate the NLRP3 inflammasome. In a murine model of neutrophilic airway inflammation induced by HDM and polyinosinic-polycytidylic acid, APOE reached a concentration of 32 nmol/L in epithelial lining fluid, with associated increases in BALF IL-1β levels. APOE-dependent NLRP3 inflammasome activation in macrophages was primarily mediated through a potassium efflux-dependent mechanism.
CONCLUSION: APOE can function as an endogenous, concentration-dependent pulmonary danger signal that primes and activates the NLPR3 inflammasome in BALF macrophages from asthmatic subjects to secrete IL-1β. This might represent a mechanism through which APOE amplifies pulmonary inflammatory responses when concentrations in the lung are increased to greater than normal levels, which can occur during viral exacerbations of HDM-induced asthma characterized by neutrophilic airway inflammation. Published by Elsevier Inc.

Entities:  

Keywords:  Asthma; IL-1β; NLRP3 inflammasome; apolipoprotein E; house dust mite; macrophages

Mesh:

Substances:

Year:  2019        PMID: 30872118      PMCID: PMC9152878          DOI: 10.1016/j.jaci.2019.02.027

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   14.290


  81 in total

1.  Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples.

Authors:  Katherine J Baines; Jodie L Simpson; Lisa G Wood; Rodney J Scott; Peter G Gibson
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

Review 2.  Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme.

Authors:  Inna S Afonina; Christina Müller; Seamus J Martin; Rudi Beyaert
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

3.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

4.  House Dust Mite Allergens and the Induction of Monocyte Interleukin 1β Production That Triggers an IκBζ-Dependent Granulocyte Macrophage Colony-Stimulating Factor Release from Human Lung Epithelial Cells.

Authors:  Kruthika Sundaram; Srabani Mitra; Mikhail A Gavrilin; Mark D Wewers
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

5.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

6.  Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma.

Authors:  S R Kim; K S Lee; K B Lee; Y C Lee
Journal:  Allergy       Date:  2012-05-07       Impact factor: 13.146

Review 7.  Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.

Authors:  Xianglan Yao; Elizabeth M Gordon; Debbie M Figueroa; Amisha V Barochia; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

8.  Metabolic hormones, apolipoproteins, adipokines, and cytokines in the alveolar lining fluid of healthy adults: compartmentalization and physiological correlates.

Authors:  Carlos O Mendivil; Henry Koziel; Joseph D Brain
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

9.  Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice.

Authors:  Nicole C Stowell; Jonathan Seideman; Holly A Raymond; Karen A Smalley; Roberta J Lamb; Devon D Egenolf; Peter J Bugelski; Lynne A Murray; Paul A Marsters; Rachel A Bunting; Richard A Flavell; Lena Alexopoulou; Lani R San Mateo; Don E Griswold; Robert T Sarisky; M Lamine Mbow; Anuk M Das
Journal:  Respir Res       Date:  2009-06-01

10.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

Authors:  Rebecca C Coll; Avril A B Robertson; Jae Jin Chae; Sarah C Higgins; Raúl Muñoz-Planillo; Marco C Inserra; Irina Vetter; Lara S Dungan; Brian G Monks; Andrea Stutz; Daniel E Croker; Mark S Butler; Moritz Haneklaus; Caroline E Sutton; Gabriel Núñez; Eicke Latz; Daniel L Kastner; Kingston H G Mills; Seth L Masters; Kate Schroder; Matthew A Cooper; Luke A J O'Neill
Journal:  Nat Med       Date:  2015-02-16       Impact factor: 53.440

View more
  22 in total

1.  Apolipoprotein E and Periostin Are Potential Biomarkers of Nasal Mucosal Inflammation. A Parallel Approach of In Vitro and In Vivo Secretomes.

Authors:  Youn Wook Chung; Jimin Cha; Seunghan Han; Yong Chen; Marjan Gucek; Hyung-Ju Cho; Kiichi Nakahira; Augustine M K Choi; Ji-Hwan Ryu; Joo-Heon Yoon
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

Review 2.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

Review 3.  Trained immunity in type 2 immune responses.

Authors:  Franziska Hartung; Julia Esser-von Bieren
Journal:  Mucosal Immunol       Date:  2022-09-05       Impact factor: 8.701

4.  Single-cell RNA sequencing and binary hierarchical clustering define lung interstitial macrophage heterogeneity in response to hypoxia.

Authors:  Nzali V Campbell; Claudia Mickael; Sushil Kumar; Hui Zhang; Ian L Campbell; Austin E Gillen; Caio O Trentin; Katrina Diener; Bifeng Gao; Vitaly O Kheyfets; Sue Gu; Rahul Kumar; Tzu Phang; R Dale Brown; Brian B Graham; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-05-24       Impact factor: 6.011

5.  Apolipoprotein E Signals via TLR4 to Induce CXCL5 Secretion by Asthmatic Airway Epithelial Cells.

Authors:  Or Kalchiem-Dekel; Xianglan Yao; Amisha V Barochia; Maryann Kaler; Debbie M Figueroa; William B Karkowsky; Elizabeth M Gordon; Meixia Gao; Maria M Fergusson; Xuan Qu; Poching Liu; Yuesheng Li; Fayaz Seifuddin; Mehdi Pirooznia; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

Review 6.  Update in Adult Asthma 2020.

Authors:  Andrew J Halayko; Christopher D Pascoe; Jessica D Gereige; Michael C Peters; Robyn T Cohen; Prescott G Woodruff
Journal:  Am J Respir Crit Care Med       Date:  2021-08-15       Impact factor: 21.405

7.  Apolipoprotein E in Asthmatic Inflammatory Response: Friend or Foe?

Authors:  Shugang Qin; Qinqin Pu; Zhihan Wang; Min Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

8.  COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches.

Authors:  Alexander V Sorokin; Sotirios K Karathanasis; Zhi-Hong Yang; Lita Freeman; Kazuhiko Kotani; Alan T Remaley
Journal:  FASEB J       Date:  2020-06-26       Impact factor: 5.191

9.  Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019.

Authors:  Scott W Canna; Grant S Schulert; Adriana de Jesus; Alex Pickering; Hermine Brunner; Massimo Gadina; Stewart Levine; Raphaela Goldbach-Mansky; Jonathan Boutelle; Rashmi Sinha; Fabrizio DeBenedetti; Alexei Grom
Journal:  Pediatr Rheumatol Online J       Date:  2020-07-15       Impact factor: 3.054

Review 10.  Targeting NLRP3 Inflammasome Activation in Severe Asthma.

Authors:  Efthymia Theofani; Maria Semitekolou; Ioannis Morianos; Konstantinos Samitas; Georgina Xanthou
Journal:  J Clin Med       Date:  2019-10-04       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.